- Home
- OMCL vs RXRX Comparison
OMCL vs RXRX Comparison
Compare OMCL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- RXRX
- Stock Information
- Founded
- OMCL 1992
- RXRX 2013
- Country
- OMCL United States
- RXRX United States
- Employees
- OMCL N/A
- RXRX N/A
- Industry
- OMCL Computer Manufacturing
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- OMCL Technology
- RXRX Health Care
- Exchange
- OMCL Nasdaq
- RXRX Nasdaq
- Market Cap
- OMCL 1.3B
- RXRX 2.0B
- IPO Year
- OMCL 2001
- RXRX 2021
- Fundamental
- Price
- OMCL $29.84
- RXRX $5.25
- Analyst Decision
- OMCL Buy
- RXRX Buy
- Analyst Count
- OMCL 6
- RXRX 5
- Target Price
- OMCL $44.83
- RXRX $7.00
- AVG Volume (30 Days)
- OMCL 476.7K
- RXRX 32.1M
- Earning Date
- OMCL 07-31-2025
- RXRX 08-07-2025
- Dividend Yield
- OMCL N/A
- RXRX N/A
- EPS Growth
- OMCL N/A
- RXRX N/A
- EPS
- OMCL 0.45
- RXRX N/A
- Revenue
- OMCL $1,135,755,000.00
- RXRX $59,790,000.00
- Revenue This Year
- OMCL $3.84
- RXRX $23.51
- Revenue Next Year
- OMCL $4.07
- RXRX $53.87
- P/E Ratio
- OMCL $65.88
- RXRX N/A
- Revenue Growth
- OMCL 3.00
- RXRX 29.32
- 52 Week Low
- OMCL $22.66
- RXRX $3.79
- 52 Week High
- OMCL $55.75
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- OMCL 53.19
- RXRX 55.15
- Support Level
- OMCL $28.80
- RXRX $4.91
- Resistance Level
- OMCL $30.57
- RXRX $5.44
- Average True Range (ATR)
- OMCL 0.78
- RXRX 0.36
- MACD
- OMCL 0.10
- RXRX 0.01
- Stochastic Oscillator
- OMCL 74.56
- RXRX 72.37
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.